A new study discovers molecular pathways that could lead to new targeted therapies which may potentially treat Glioblastoma, the most common and lethal form of brain cancer in adults.
By altering DON, an anti-cancer drug cultivated from bacteria originally found in Peruvian soil over 70 years ago, scientists believe they have made a safer and more tolerable form of the drug.
Researchers uncover a possible reason as to why astrocytomas don't respond to standard forms of cancer treatment.
Combining αGITR antibodies with ICBs resulted in stronger survival benefits in mouse models of human glioblastoma brain cancer.
Researchers suggest neural stem cells could be resistant to radiation. The stem cells could be roused from a hibernation-like state in order to reproduce and generate new cells which have the ability to migrate, replace injured cells and restore lost function.